Immunovant, Inc. (IMVT) vs Ionis Pharmaceuticals, Inc. (IONS)
Immunovant, Inc. and Ionis Pharmaceuticals, Inc. are both Biotechnology companies. Immunovant, Inc. and Ionis Pharmaceuticals, Inc. are of similar size ($7.4B and $7.1B). Immunovant, Inc. has the higher net margin (0.00% vs −64.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Immunovant, Inc. leads on 8 and Ionis Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | IMVT | IONS | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 98.17% | 65.16% |
| Operating margin | 0.00% | (68.00%) | 0.00% |
| Net margin | 0.00% | (64.66%) | 0.00% |
| Free cash flow margin | 0.00% | (64.93%) | 0.00% |
| Return on equity | (80.10%) | (105.50%) | (57.72%) |
| Return on assets | (71.10%) | (18.90%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack